Some price data may be temporarily unavailable.
The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
In an industry in which many biotech companies focus only on diseases that affect huge numbers of people, Reata provides some diversification with its focus on orphan conditions.
A buyout deal recently pushed Reata Pharmaceuticals stock 53% higher in a single trading session, leading investors to wonder who's next.
The gains these stocks notched in the first few months of the year could be the beginning of a much longer bull run.
RETA earnings call for the period ending September 30, 2021.
RETA earnings call for the period ending June 30, 2021.
RETA earnings call for the period ending March 31, 2021.
RETA earnings call for the period ending December 31, 2020.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.